Probiotic to improve IBS quality of life

Recommended by professional guidelines for the treatment of Irritable Bowel Syndrome (IBS)

Know more about i3.1:

Better IBS-related quality of life

Improves gut hypersensitivity

Helps regulate bowel movement

i3.1 is endorsed by several top-class gastrointestinal societies: 

World Gastroenterology Organisation

Probiotics and prebiotics guideline, as a clinically-tested treatment for IBS

German Society of Gastroenterology

German S3-guideline for IBS, as a recommended microbiota-modulator treatment

i3.1 is the only probiotic that improves visceral hypersensitivity

Visceral hypersensitivity is defined as the abnormal sensation of intestinal pain, commonly found in IBS patients

AB-KOLICARE presents a well-described and unique mechanism of action:

High inhibitory activity against enteropathogens
Fast digestion of HMOs
Induction of anti-inflammatory molecules


Proprietary probiotic strains naturally found in the gut of healthy individuals. Only essential ingredients

tested as a co-treatment

Can be taken together with anti-spasmodics to increase therapeutic benefits, specially for abdominal pain

also for lactose intolerance

Improves general symptoms of lactose intolerance, including pain, flatulence and diarrea

clinically proven and safe

Three clinical trials with IBS and lactose intolerant patients. Safety approved by EFSA and FDA

Supplement that fits all diets: vegan certificate, plant-based origin.

+ 0
Patients tested

Widely studied in clinical trials, and in vivo, in vitro studies

Download the product's scientific brochure to know more:

×ATENCIÓ: Cookies no configurades en l'idioma actual. Revisa la teva configuració al plugin, gràcies!

Subscribe to our newsletter!